Marcus R Duvall - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Current Drug Discovery Technologies|January 22, 2014

Different approaches for obtaining antibodies from human B cellsMarcus R Duvall, Ryan N Fiorini

Medical Hypotheses|January 14, 2009

Back-burning to cure HIV: temporary depletion of all CD4+ cells and elimination of the extracellular reservoir with HIV immunotoxin therapyMary K B Zanin, Marcus R Duvall

Immunobiology|July 10, 2009

Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cellsMarcus R Duvall, Hee Young Hwang, Robert J Boackle

Molecular Immunology|March 4, 2008

Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragmentHee Young Hwang, Marcus R Duvall, Stephen Tomlinson, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Current Drug Discovery Technologies|January 22, 2014

Different approaches for obtaining antibodies from human B cellsMarcus R Duvall, Ryan N Fiorini

Medical Hypotheses|January 14, 2009

Back-burning to cure HIV: temporary depletion of all CD4+ cells and elimination of the extracellular reservoir with HIV immunotoxin therapyMary K B Zanin, Marcus R Duvall

Immunobiology|July 10, 2009

Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cellsMarcus R Duvall, Hee Young Hwang, Robert J Boackle

Molecular Immunology|March 4, 2008

Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragmentHee Young Hwang, Marcus R Duvall, Stephen Tomlinson, et al.

Pageof 1